Ipsen acquires Syntaxin - MarketLine Financial Deals

Ipsen acquires Syntaxin

Ipsen acquires Syntaxin - MarketLine Financial Deals
Ipsen acquires Syntaxin
Published Jul 15, 2013
5 pages — Published Jul 15, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report


Ipsen S.A., a France-based pharmaceutical company, has acquired Syntaxin, Ltd.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Ipsen acquires Syntaxin" Jul 15, 2013. Alacra Store. Jun 24, 2018. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ipsen-acquires-Syntaxin-2052-96243>
MarketLine Financial Deals. (2013). Ipsen acquires Syntaxin Jul 15, 2013. New York, NY: Alacra Store. Retrieved Jun 24, 2018 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ipsen-acquires-Syntaxin-2052-96243>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.